The emerging arrival of the 40mg Tirzepatide dose represents a possibly significant advancement in the treatment of type 2 diabetes . This therapy builds upon the existing success of lower amounts, showing promising results in improving blood sugar levels and supporting weight loss . Clinicians are investigating its complete benefit on heart health